Sales to Dolphin commenced in March 2020 to assist RedHawk satisfy increased product demand.
RedHawk appoints Dolphin Medical as exclusive SANDD distributor. (Credit: Free-Photos from Pixabay.)
LAFAYETTE, Louisiana, March 23, 2020 /PRNewswire/ — RedHawk Holdings Corp. (OTC: SNDD) (“RedHawk” or the “Company”), a diversified holding company engaged primarily in sales and distribution of medical devices, announced today that it has entered into an agreement (the “Agreement”) with Florida-based Dolphin Medical LLC (“Dolphin”) for the exclusive distribution of RedHawk’s line of needle incineration devices (“SANDD™”) for the States of Alabama, Georgia, Mississippi, Tennessee and portions of Florida (collectively “the Territories”).
Under the Agreement, Dolphin has committed, among other things, to purchase annually from RedHawk for resale in the Territories, 6,000 SANDD mini™, SANDD HP™ or SANDD FR™ needle incineration devices, 2,000 SANDD Pro™ needle incineration devices and certain other medical supplies. The Agreement provides that RedHawk will sell the SANDD™ devices to Dolphin at list price less a customary distributor discount. Certain volume discounts are also available to Dolphin.
Source: Company Press Release